Despite improved survival outcomes across many cancer types, the prognosis remains grim
for certain solid organ cancers including glioblastoma and pancreatic cancer. Invariably in …

Introduction As a novel treatment modality, tumor treating fields (TTFields) exert low-
intensity, medium-frequency electric fields on tumor cells. TTFields' effectiveness and safety …

Exposing cancer cells to alternating electric fields of 100-300 kHz frequency and 1-4 V/cm
strength has been shown to significantly reduce cancer growth in cell culture and in human …

Despite major advances in therapy, cancer continues to be a leading cause of mortality. In
addition, toxicities of traditional therapies pose a significant challenge to tolerability and …

Background Malignant brain tumors are among the most threatening diseases of the central
nervous system, and despite increasingly updated treatments, the prognosis has not been …

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related deaths
worldwide. Common treatment modalities for NSCLC include surgery, radiotherapy …

Tumor treating fields (TTFields)-an intermediate-frequency, electric field therapy-has
emerged as a promising alternative therapy for the treatment of solid cancers. Since the first …

Introduction: Local control is fundamental, both for the curative as well as the palliative
treatment of cancer. Tumor treating fields (TTFields) are low intensity (1–2 V/cm) …

Although major innovations in treatment are advancing, cancer persists as one of the
leading causes of mortality. With the rising incidence of cancer and as we treat them …

The standard of care for patients with newly diagnosed Glioblastoma multiforme (GBM) has
remained unchanged since 2005, with patients undergoing maximal surgical resection …